Compare RCUS & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCUS | KNTK |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2018 | 2017 |
| Metric | RCUS | KNTK |
|---|---|---|
| Price | $19.64 | $46.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | $28.22 | ★ $46.45 |
| AVG Volume (30 Days) | 913.0K | ★ 1.5M |
| Earning Date | 05-28-2026 | 05-29-2026 |
| Dividend Yield | N/A | ★ 7.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | ★ $247,000,000.00 | $160,617,000.00 |
| Revenue This Year | N/A | $27.32 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ N/A | $106.12 |
| Revenue Growth | N/A | ★ 8.23 |
| 52 Week Low | $6.79 | $31.33 |
| 52 Week High | $26.40 | $59.74 |
| Indicator | RCUS | KNTK |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 70.63 |
| Support Level | $8.86 | $42.85 |
| Resistance Level | $21.55 | $47.19 |
| Average True Range (ATR) | 1.09 | 2.05 |
| MACD | 0.03 | 0.22 |
| Stochastic Oscillator | 36.70 | 83.20 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.